1 |
Puccetti M, Gomes Dos Reis L, Pariano M, Costantini C, Renga G, Ricci M, Traini D, Giovagnoli S. Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection. Int J Pharm 2021;607:121004. [PMID: 34391857 DOI: 10.1016/j.ijpharm.2021.121004] [Reference Citation Analysis]
|
2 |
D'Onofrio F, Renga G, Puccetti M, Pariano M, Bellet MM, Santarelli I, Stincardini C, Mosci P, Ricci M, Giovagnoli S, Costantini C, Romani L. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021;10:1622. [PMID: 34209524 DOI: 10.3390/cells10071622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Puccetti M, Pariano M, Costantini C, Giovagnoli S, Ricci M. Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation. Pharmaceuticals 2022;15:336. [DOI: 10.3390/ph15030336] [Reference Citation Analysis]
|
4 |
Renga G, Nunzi E, Pariano M, Puccetti M, Bellet MM, Pieraccini G, D'Onofrio F, Santarelli I, Stincardini C, Aversa F, Riuzzi F, Antognelli C, Gargaro M, Bereshchenko O, Ricci M, Giovagnoli S, Romani L, Costantini C. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite. J Immunother Cancer 2022;10:e003725. [PMID: 35236743 DOI: 10.1136/jitc-2021-003725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Kamble O, Chatterjee R, Dandela R, Shinde S. Ultrasonic energy for construction of bioactive heterocycles. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.132893] [Reference Citation Analysis]
|